Brynn B. Duncan

Hematology | Oncology
1800 Orleans St Ste 11379
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Quadriparesis after CD19 × CD22 bicistronic chimeric antigen receptor T cells for B-cell acute lymphoblastic leukaemia.

Quadriparesis after CD19 × CD22 bicistronic chimeric antigen receptor T cells for B-cell acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: March 20, 2025

Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells.

Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells.

Journal: Molecular therapy. Methods & clinical development
Published: January 27, 2025

Evolving strategies for addressing CAR T-cell toxicities.

Evolving strategies for addressing CAR T-cell toxicities.

Journal: Cancer metastasis reviews
Published: May 16, 2024

Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag.

Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag.

Journal: British journal of haematology
Published: December 03, 2023

Applying a clinical lens to animal models of CAR-T cell therapies.

Applying a clinical lens to animal models of CAR-T cell therapies.

Journal: Molecular therapy. Methods & clinical development
Published: September 26, 2022

Unresectable Metastatic Testicular Germ Cell Tumor With Low-grade Neuroglial Neoplasm, Stable After Radiation and Chemotherapy.

Unresectable Metastatic Testicular Germ Cell Tumor With Low-grade Neuroglial Neoplasm, Stable After Radiation and Chemotherapy.

Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: April 01, 2022

CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease.

CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease.

Journal: Current hematologic malignancy reports
Published: August 19, 2018

Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor.

Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor.

Journal: Blood
Published: December 04, 2017

A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines.

A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines.

Journal: Vaccine
Published: October 30, 2013

A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy.

A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 03, 2013

Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.

Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 01, 2013

Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors.

Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors.

Journal: PloS one
Published: November 20, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026